Survival outcomes, hematologic complications and growth impairment after sequential chemoradiotherapy in intracranial NGGCTs: a  retrospective study

ConclusionOur study suggested that a  combined treatment modality with at least four cycles of chemotherapy and CSI was safe and effective for patients with intracranial NGGCTs. Radiotherapy should be used with caution for patients<  11.5 years due to growth impairment.
Source: Strahlentherapie und Onkologie - Category: Cancer & Oncology Source Type: research